Blood Research

Cited by CrossRef (20)

  1. Eman Mostafa Hamed, Mohamed Hussein Meabed, Ahmed R. N. Ibrahim, Ahmed M. Khalaf, Doaa Mohamed El Demerdash, Marwa O. Elgendy, Haitham Saeed, Tamer M. Mahmoud, Heba F. Salem, Hoda Rabea. Clinical Care Team’s Guide for Awareness on Risk Assessment of Eltrombopag Complicating Acute Kidney Injury in Relapsed Immune Thrombocytopenic Patients: A Case Report. Medicina 2023;59:1645
    https://doi.org/10.3390/medicina59091645
  2. Nicole Rainville, Edward Jachimowicz, Don M Wojchowski. Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis. Expert Opinion on Therapeutic Targets 2016;20:287
    https://doi.org/10.1517/14728222.2016.1090975
  3. Adam Cuker, Jenny M. Despotovic, Rachael F. Grace, Caroline Kruse, Michele P. Lambert, Howard A. Liebman, Roger M. Lyons, Keith R. McCrae, Vinod Pullarkat, Jeffrey S. Wasser, David Beenhouwer, Sarah N. Gibbs, Irina Yermilov, Michael S. Broder. Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method. Research and Practice in Thrombosis and Haemostasis 2021;5:69
    https://doi.org/10.1002/rth2.12457
  4. Li Liu, Yilin Chen, Yan Liang, Li Meng, Jingming Guo, Chuancai Liu, Zhe Zhao, Jing Zou, Wenjuan He, Jiangzhao Zhang, Zhenya Hong, Caixia Liang, Xianjie Fu, Hui Wu, Youshan Zhang, Yanli Zhang, Weiming Li. The efficacy and safety of eltrombopag in treating TKI-induced thrombocytopenia in patients with chronic myeloid leukemia. Hematology 2023;28
    https://doi.org/10.1080/16078454.2023.2248434
  5. Esma Evrim Dogan, Esra Turan Erkek, Tugrul Elverdi, Sule Celik Kamaci, Ugur Ciftci, Naciye Demirel, Demet Aydin, Rafet Eren. Eltrombopag in the Treatment of Immune Thrombocytopenia: Two-Center Experience from Istanbul. Indian J Hematol Blood Transfus 2022;38:327
    https://doi.org/10.1007/s12288-021-01462-5
  6. Liping Xu, Yan Zhang, Na Lin, Xinwei Song, Qiaoding Dai. Eltrombopag improves refractory thrombocytopenia in patients with Sjögren's syndrome. Science Progress 2022;105:003685042211027
    https://doi.org/10.1177/00368504221102786
  7. Rojin Park. Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia. Blood Res 2015;50:1
    https://doi.org/10.5045/br.2015.50.1.1
  8. Hyun Jin Ahn, Ja Min Byun, Inho Kim, Jeonghwan Youk, Youngil Koh, Dong-Yeop Shin, Junshik Hong, Sung-Soo Yoon. Eltrombopag for Post-Transplant Poor Graft Function in East Asian Patients. J Korean Med Sci 2022;37
    https://doi.org/10.3346/jkms.2022.37.e48
  9. Yu Dong, Zhinan Xia, Jie Zhou, Yutao Hu, Ming Yue, Yuyong Wang, Mengjiao Hu. Risk of thrombotic events in immune thrombocytopenia patients treated with thrombopoietic agents: a systematic review and meta-analysis. Thrombosis J 2023;21
    https://doi.org/10.1186/s12959-023-00509-z
  10. Russell K. Brynes, Raymond S.M. Wong, Maung M. Thein, Kalpana K. Bakshi, Paul Burgess, Dickens Theodore, Attilio Orazi. A 2-Year, Longitudinal, Prospective Study of the Effects of Eltrombopag on Bone Marrow in Patients with Chronic Immune Thrombocytopenia. Acta Haematol 2017;137:66
    https://doi.org/10.1159/000452992
  11. Kundan Mishra, Kamal Kant Sahu. Re: Risk factors and predictors of treatment responses and complications in immune thrombocytopenia. Ann Hematol 2022;101:447
    https://doi.org/10.1007/s00277-021-04476-1
  12. Heng Mei, Min Xu, Guolin Yuan, Feiyue Zhu, Jingming Guo, Ruibin Huang, Jun Qin, Tingting Lv, Fangmei Qin, Huili Cai, Ping Yin, Tingting Qin, Yu Hu. A multicentre double‐blind, double‐dummy, randomised study of recombinant human thrombopoietin versus eltrombopag in the treatment of immune thrombocytopenia in Chinese adult patients. Br J Haematol 2021;195:781
    https://doi.org/10.1111/bjh.17808
  13. Simone Birocchi, Gian Marco Podda, Marco Manzoni, Giovanni Casazza, Marco Cattaneo. Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review. Platelets 2021;32:216
    https://doi.org/10.1080/09537104.2020.1745168
  14. Jiaxing Zhang, Yi Liang, Yuan Ai, Xiaosi Li, Juan Xie, Youping Li, Wenyi Zheng, Rui He, Gualtiero I. Colombo. Eltrombopag versus romiplostim in treatment of adult patients with immune thrombocytopenia: A systematic review incorporating an indirect-comparison meta-analysis. PLoS ONE 2018;13:e0198504
    https://doi.org/10.1371/journal.pone.0198504
  15. Massimiliano Palombi, Laura Scaramucci, Marco Giovannini, Malgorzata Monika Trawinska, Pasquale Niscola, Paolo de Fabritiis. Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?. Blood Res 2016;51:66
    https://doi.org/10.5045/br.2016.51.1.66
  16. Yi-Hong Wu, Hsing-Yu Chen, Chyong-Huey Lai, Chein-Shuo Yeh, Jong-Hwei S. Pang, Jian-Tai Qiu, Hung-Hsueh Chou, Lan-Yan Yang, Yu-Bin Pan. Use of Chinese Herbal Medicine Improves Chemotherapy-Induced Thrombocytopenia among Gynecological Cancer Patients: An Observational Study. Evidence-Based Complementary and Alternative Medicine 2018;2018:1
    https://doi.org/10.1155/2018/4201325
  17. Mohamed A Yassin, Rola Ghasoub, Ashraf Soliman, Omar Ismail, Abdulqadir J Nashwan, Awni Alshurafa, Firdous Ghori, Deena Sideeg, Anas Hamad, Radwa Hussein, Randa Al-Okka, Prem Chandra, Aya Alasmar. The Impact of Ethnicity on the Response to Eltrombopag in Patients With Immune Thrombocytopenia (ITP) in Qatar: A Single Institution Experience. 2022
    https://doi.org/10.7759/cureus.25701
  18. Hyun Ji Lim, Young Tae Lim, Jeong Ok Hah, Jae Min Lee. Delayed treatment-free response after romiplostim discontinuation in pediatric chronic immune thrombocytopenia. Yeungnam Univ J Med 2021;38:165
    https://doi.org/10.12701/yujm.2020.00493
  19. Erjola Bidika, Hafsa Fayyaz, Marina Salib, Areeba N Memon, Asavari S Gowda, Bhavana Rallabhandi, Ivan Cancarevic. Romiplostim and Eltrombopag in Immune Thrombocytopenia as a Second-Line Treatment. 2020
    https://doi.org/10.7759/cureus.9920
  20. Eun‐Ju Lee, Hanny Al‐Samkari. TPO versus TPO: the good, the bad, and the to be determined. Br J Haematol 2021;195:653
    https://doi.org/10.1111/bjh.17825
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd